Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

NCT01261325 ·Status: COMPLETED ·Phase: PHASE3

Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

NCT04879433 ·Status: UNKNOWN

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

NCT00232596 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

NCT00744731 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters

NCT02161185 ·Status: TERMINATED ·Phase: PHASE3

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

NCT00310375 ·Status: COMPLETED ·Phase: PHASE3

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

NCT00235755 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

NCT04715646 ·Status: RECRUITING ·Phase: PHASE3

Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy

NCT02726919 ·Status: UNKNOWN ·Phase: PHASE4

This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment

NCT00150800 ·Status: COMPLETED ·Phase: PHASE3

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

NCT01235403 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

NCT01529034 ·Status: TERMINATED ·Phase: PHASE3

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

NCT04529954 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

NCT00422422 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS

NCT04557085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

NCT00210652 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures

NCT01964560 ·Status: COMPLETED ·Phase: PHASE3

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

NCT03678753 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322 ·Status: RECRUITING ·Phase: PHASE3

Remegal Different Doses in Patients With Refractory Partial Seizures

NCT01179854 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

NCT00228969 ·Status: COMPLETED ·Phase: PHASE2

Expanded Use of Cannabidiol Oral Solution

NCT03196934 ·Status: NO_LONGER_AVAILABLE

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

NCT04686786 ·Status: TERMINATED ·Phase: PHASE2

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

NCT04903314 ·Status: COMPLETED ·Phase: PHASE1